These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25626701)

  • 1. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
    Lebasnier A; Lamotte G; Manrique A; Peyronnet D; Bouvard G; Defer G; Agostini D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1043-51. PubMed ID: 25626701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
    Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
    Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
    J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses.
    Lamotte G; Morello R; Lebasnier A; Agostini D; Defer GL
    BMC Neurol; 2015 May; 15():83. PubMed ID: 25971430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
    Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
    Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].
    Marquié Sayagués M; Da Silva Alves L; Molina-Porcel L; Alcolea Rodríguez D; Sala Matavera I; Sánchez-Saudinós MB; Camacho Martí V; Estorch Cabrera M; Blesa González R; Blesa González R; Gómez-Isla T; Gómez-Isla T; Lleó Bisa A; Lleó Bisa A
    Neurologia; 2010 Sep; 25(7):414-21. PubMed ID: 20964987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential diagnostic value of
    Abbasi M; Ghalandari N; Farzanefar S; Aghamollaii V; Ahmadi M; Ganji M; Afarideh M; Loloee S; Naseri M; Tafakhori A
    Clin Neurol Neurosurg; 2017 Dec; 163():163-166. PubMed ID: 29112909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
    Sakamoto F; Shiraishi S; Ogasawara K; Tsuda N; Nakagawa M; Tomiguchi S; Yamashita Y
    Ann Nucl Med; 2020 Jun; 34(6):415-423. PubMed ID: 32301068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of dementia with Lewy bodies: can
    Sakamoto F; Shiraishi S; Tsuda N; Hashimoto M; Tomiguchi S; Ikeda M; Yamashita Y
    Br J Radiol; 2017 Feb; 90(1070):20160156. PubMed ID: 27897064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
    Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K
    J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
    Tateno M; Kobayashi S; Shirasaka T; Furukawa Y; Fujii K; Morii H; Yasumura S; Utsumi K; Saito T
    Dement Geriatr Cogn Disord; 2008; 26(5):453-7. PubMed ID: 18974648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
    Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early alteration of adrenergic cardiac function in parkinsonisms with Lewy bodies].
    Jiménez-Hoyuela García JM; Campos Arillo V; Rebollo Aguirre AC; Gómez Doblas JJ; Gutiérrez Hurtado A
    Rev Esp Med Nucl; 2005; 24(2):93-100. PubMed ID: 15745679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of dementia with Lewy bodies: diagnostic performance of combined ¹²³I-IMP brain perfusion SPECT and ¹²³I-MIBG myocardial scintigraphy.
    Sakamoto F; Shiraishi S; Yoshida M; Tomiguchi S; Hirai T; Namimoto T; Hashimoto M; Ikeda M; Uetani H; Yamashita Y
    Ann Nucl Med; 2014 Apr; 28(3):203-11. PubMed ID: 24363079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
    Odagiri H; Baba T; Nishio Y; Iizuka O; Matsuda M; Inoue K; Kikuchi A; Hasegawa T; Aoki M; Takeda A; Taki Y; Mori E
    PLoS One; 2016; 11(4):e0152746. PubMed ID: 27055151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autopsy Validation of the Diagnostic Accuracy of
    Matsubara T; Kameyama M; Tanaka N; Sengoku R; Orita M; Furuta K; Iwata A; Arai T; Maruyama H; Saito Y; Murayama S
    Neurology; 2022 Apr; 98(16):e1648-e1659. PubMed ID: 35256483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.